Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that proper diagnosis and combined treatments are key for hirsutism management, and weight loss may help overweight patients.

Some patients lost hair after being treated with the drug enoxaparin for a brain vein clot.

Sonidegib and vismodegib are similarly effective for advanced basal cell carcinoma, but sonidegib might have a slightly better safety profile.

New melanoma treatments can cause skin side effects, including skin cancer and rashes, but combining treatments may reduce these risks.

Potassium channel openers show promise for treating heart disease and other conditions, but more research is needed to fully understand their effects and safety.

Toxic Epidermal Necrolysis is a rare, serious skin condition that can affect anyone, is more common in women, and may be linked to genetics, with a 20% mortality rate mainly due to sepsis.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

The 2018 update to the ED care model added a new severity score and stressed a detailed evaluation of both physical and psychological aspects.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

Stress affects skin health and emotional well-being should be considered in skin disease treatment.

Endoxan often causes hair loss, which usually starts in the third week of treatment.

Anti-cancer treatments can cause reversible hair loss, skin sensitivity, pigmentation changes, nail damage, and skin reactions, with a need for more research on managing these side effects.

High-potency steroids or tacrolimus are effective treatments for Erosive Pustular Dermatosis of the Scalp.

Inositol was not more effective than a placebo in treating trichotillomania.

Early diagnosis and aggressive treatment are key for managing rare scalp disorders that cause permanent hair loss.

Chemotherapy and cytokine therapy can cause various skin reactions, including hair loss and hypersensitivity.

The article concludes that hair loss is a common side effect of drugs treating skin cancer by blocking the hedgehog pathway, but treatment should continue, and more selective drugs might prevent this side effect.

Patients with oral lichen planus or oral lichenoid reactions had worse cholesterol levels and a higher risk of obesity compared to healthy individuals.

Men with more vanadium in their blood and who drink less soy milk are more likely to have hair loss.

5α-reductase inhibitors like finasteride may not be effective or safe for transgender individuals, and more research is needed.

An emollient PLUS balm with ADE-G1 significantly improved skin dryness and quality of life in cancer patients with xerosis.

FFA in men, often mistaken for other hair loss types, may be more common than thought and needs larger studies for confirmation.

Skin changes like hair loss, white patches, and nail changes are common in children after bone marrow transplants, often linked to chronic rejection.

The conclusion is that a systematic approach is key for treating symmetrical alopecia in dogs, but treatment may not always be necessary.

A woman with acromegaly experienced severe hair loss from a drug called Lanreotide Autogel, which improved after stopping the treatment.

Finasteride worsens stress effects on sensory processes, possibly linking to anxiety/depression.

Pregnancy can cause unique skin issues, some of which may risk the mother and baby's health and need careful treatment.

Laser hair removal can cause a severe itchy rash in some allergic individuals, treatable with steroids.

Examining scalp biopsies in different ways helps better diagnose hair loss types.

The conclusion is that effective cancer treatment often requires a combination of therapies, but must be carefully managed due to serious side effects and the risk of immunosuppression.